Scholars Central

CommentaryPublished 31 Jul 2023

Impact of Growth Hormone Therapy on Quality of Life in Short Stature Children at Minya University Hospital: A Cross-Sectional Study

Authors: Noura M El Bakry, Zamzam H Mohamed

Journal of Diabetes & Metabolism

Volume 14 · Issue 7 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: If a child's height is further more two standard deviations under the mean for children of his or her sex also age, then we say that he or she has short stature. Quality of life (QOL) is a person's perception of their own state of well-being & functioning over a wide spectrum from the best possible to the worst possible. It involves psychological, physical, cognitive, social, functional & behavioral elements. QOL has also become more important in health care practice and research. Objectives: to assess the QOL in children previously both idiopathic short stature (ISS) and growth hormone deficiency (GHD) were on the list of diagnoses in addition children on treatment with growth hormone (GH) by daily injection. Methods: This cross-sectional study involved 200 children between the ages of 8 and 18 who were diagnosed to have GHD and ISS and were on treatment by GH daily injection at the Pediatric Endocrinology Unit at Minia University Hospital from March 2020 until October 2021. Results: 16% of cases were ISS, and 84% of cases had GHD. Ninety-two percent of our studied cases were already on treatment with recombinant growth hormone (rGH). Children with ISS had significantly reduced physical, psychological, & environmental quality of life. Most affected is the social domain. Comparing treated and untreated groups, there is more emotional affection in the untreated group than the treated group (p less than 0.01). An evaluation of the various sex classes (boys & girls) in respect to several domains amongst persons was made, but no statistically significant distinction was found. Conclusions: QOL was impaired in cases of short stature, whether on GH theraphy or not. However, our study showed a significant correlation between PedsQL scores for short stature and age if the first administration of treatment donating early GH therapy had better QOL scores.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Diabetes & Metabolism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Noura M El Bakry”
  • BylineArticles whose byline prints “Zamzam H Mohamed”